Edition:
United Kingdom

DURECT Corp (DRRX.OQ)

DRRX.OQ on NASDAQ Stock Exchange Global Market

0.75USD
20 Mar 2019
Change (% chg)

$0.01 (+0.77%)
Prev Close
$0.75
Open
$0.76
Day's High
$0.77
Day's Low
$0.73
Volume
27,044
Avg. Vol
112,606
52-wk High
$2.55
52-wk Low
$0.48

Chart for

About

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY... (more)

Overall

Beta: 1.81
Market Cap(Mil.): $299.88
Shares Outstanding(Mil.): 147.00
Dividend: --
Yield (%): --

Financials

  DRRX.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -0.25 -- --
ROI: -109.40 8.89 13.82
ROE: -411.96 10.00 15.25

Earnings vs. Estimates